SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IVAX Insider Trading -- Ignore unavailable to you. Want to Upgrade?


To: flickerful who wrote (435)1/19/1998 4:01:00 PM
From: 5,17,37,5,101,...  Read Replies (1) | Respond to of 756
 
<<offtopic>>

RATL looks delectable from an insider perspective. There is so much buying that one can only conclude that at $9 the company is incredibly undervalued by the market. I will buy at $10+ on a dip. Fundamentally, I still don't know anything about the market for their products. But I don't see any reason it would not be acquired, IMHO. Growth is good; products seem unique...who knows?

OLGC looks good from an insider perspective also. I would be happier if I saw some nonqualified options being exercised. I will buy a little more than the usual amount to start -- 1000 shares should work and allow me to average into a pullback to the $5 area. Fundamentally, OLGC appears to have a marketing problem and a problem digesting recent acquisitions. Management seems confident that it can work through this. That conference call referred to on the thread was likely a disaster because investors are tired of waiting, and management does not want to falsely raise hopes. In many ways this stock, IMHO, resembles IDTI: it had a big run up followed by a crash and a very nice basing pattern; management has had some problems with investments and costs; management is looking to new products. It's worth a gamble here.

Brief review of finc. state.

1) Debt level is low.
2) Accounts payable way way too low relative to sales and acct. rec. This could be a permanent source of cash flow?
3) Trotter has a nice bonus compensation plan allowing for purchase of around half a million shares at later dates at present prices.
4) Book value of $3.3
5) Institutional investors increased positions as of 9/97 (stocksmart)

Jackson